COGNICURRENT

Jan 2 • 22:00 UTC • 🇨🇳 China • South China Morning Post

China’s biopharma sector ‘in prime position to challenge US leadership’

China's biopharma industry is advancing into an 'innovation 2.0' phase that positions it to potentially overtake US leadership in the sector.

#biopharma #china #us #innovation #trade

Read Original Back to Feed

📡 Similar Coverage

🇨🇳 China Feb 11 • 06:00 UTC

Capital injection: China backs AI drug makers in self-reliance drive

South China Morning Post

🇨🇳 China Jan 8 • 00:30 UTC

Chinese drug makers strike a record US$136 billion in out-licensing deals in 2025

South China Morning Post

🇮🇳 India Feb 18 • 22:44 UTC

China’s Dominance in the Sea is Rapidly Increasing... Leaving the US Behind in Submarine Production

Aaj Tak (Hindi)

🇨🇳 China Jan 12 • 02:30 UTC

China AI has ‘less than 20%’ chance to exceed US over next 3 to 5 years: Alibaba scientist

South China Morning Post

🇨🇳 China Jan 3 • 03:00 UTC

Tech war: China takes confident strides to develop more AI innovation in 2026

South China Morning Post

🇨🇳 China Feb 10 • 05:00 UTC

Chinese investors pour into Hong Kong-listed drug stocks as international deals multiply

South China Morning Post